Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Other Non Operating Income (2023 - 2025)

Volitionrx (VNRX) has disclosed Other Non Operating Income for 3 consecutive years, with -$308801.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 239480.62% year-over-year to -$308801.0, compared with a TTM value of $33993.0 through Sep 2025, up 111.86%, and an annual FY2024 reading of -$233015.0, down 196.96% over the prior year.
  • Other Non Operating Income was -$308801.0 for Q3 2025 at Volitionrx, down from $373588.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $373588.0 in Q2 2025 and bottomed at -$308801.0 in Q3 2025.
  • Average Other Non Operating Income over 3 years is $11717.6, with a median of -$34813.5 recorded in 2024.
  • Peak annual rise in Other Non Operating Income hit 635.56% in 2025, while the deepest fall reached 239480.62% in 2025.
  • Year by year, Other Non Operating Income stood at -$129436.0 in 2023, then surged by 41.37% to -$75887.0 in 2024, then plummeted by 306.92% to -$308801.0 in 2025.
  • Business Quant data shows Other Non Operating Income for VNRX at -$308801.0 in Q3 2025, $373588.0 in Q2 2025, and $45093.0 in Q1 2025.